Stephen J.LurieMD, PhD, Senior Editor
To the Editor: As a rural family physician with a large population of African American patients, who disproportionately experience greater smoking-attributable morbidity and mortality,1 I am constantly searching for ways to reduce health disparities associated with smoking. I agree with Drs Pierce and Gilpin2 that prescription benefit support of pharmaceutical cessation aids reduces the cost disincentives for their use. Many of my patients have such coverage. However, the most important factor in use of smoking cessation aids in African American and Hispanic patients in rural areas is access to information.
Cadore JM. Effectiveness of Over-the-Counter Nicotine Replacement Therapy. JAMA. 2002;288(24):3108. doi:10.1001/jama.288.24.3108-JLT1225-1-3